ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0K95 Northwest Biotherapeutics Inc

0.171
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Northwest Biotherapeutics Financial Summary

The current 0K95 market cap is 197.31M. The company's latest EPS is USD -0.0558 and P/E is -3.05.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.41M1.29M1.01M1.68M1.93M
Operating Income -27.46M-86.61M-52.7M-67.18M-55.51M
Net Income -20.3M-529.82M179.13M-105.03M-64.37M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 9.13M32.9M40.16M31.32M27.87M
Total Liabilities 52.7M395.85M164.15M136.37M74.92M
Total Equity -43.57M-362.95M-123.99M-128.1M-65.77M

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -31.86M-32.09M-38.3M-52.78M-53.64M
Investing -360k-8.14M-6.02M-2.9M-3.44M
Financing 9.95M52.7M48.13M41.97M52.76M
Market Cap 197.31M
Price to Earnings Ratio -3.05
Price to Sales Ratio 100
Price to Cash Ratio 94.44
Price to Book Ratio -4.17
Dividend Yield -

Share Statistics

Shares Outstanding 1.15B
Average Volume (1 week) 0
Average Volume (1 Month) 12.28k
52 Week Change 0.00%
52 Week High 0.171
52 Week Low 0.171
Spread (Intraday) 0 (0%)

Company Info

Company Name Northwest Biotherapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock